Wilmington, Del., May 28, 2025 (GLOBE NEWSWIRE) -- Ashland will host an Innovation Day for analysts and investors at the company’s Bridgewater, New Jersey facility on May 29, 2025. The event will showcase the enhanced capabilities and expanded applications of Ashland's scalable technology platforms. Registration is required with options to attend via live webcast or in person. To register, visit the following link: registration page Participants will join Ashland’s executive and senior technology leaders fo ...

Ashland Global Holdings Inc. (ASH) recorded second-quarter fiscal 2025 (ended March 31, 2025) profit of $31 million or 65 cents, down from $120 million or $2.39 in the prior-year quarter.Barring one-time items, adjusted earnings came in at 99 cents, down from the year-ago quarter’s figure of $1.27. The bottom line missed the Zacks Consensus Estimate of $1.10.Sales were down 16.7% year over year to $479 million. The top line missed the Zacks Consensus Estimate of $508.8 million. Sales for the fiscal second q ...

Ashland - Kevin Willis Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity Ashland - William Whitaker William C. Whitaker, vice president, finance, and director, investor relations, Ashland, will serve as the company’s interim chief financial officer until the board of directors conclude its review process. Ashland - Samuel Richardson Samuel A. Richardson, controller, Ashland, will serve as vice president, controller and pr ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 333-211719 ASHLAND INC. (a Delaware corporation) I.R.S. No. 81-2587835 8145 Blazer Drive FORM 10-Q Wilmington, Delaware 19808 Telephone Number ...

Ashland (ASH) Q2 2025 Earnings Call May 01, 2025 10:00 AM ET Company Participants William Whitaker - Director of Investor RelationsGuillermo Novo - Chair of the Board and Chief Executive OfficerJ. Kevin Willis - Senior Vice President and Chief Financial OfficerAlessandra Faccin Assis - Senior Vice President and General Manager, Life Sciences and IntermediatesJames Minicucci - Senior VP & GM of Personal CareDago Caceres - Senior Vice President and General Manager, Specialty AdditivesKevin Estok - Equity Rese ...

earnings conference call second quarter fiscal 2025 May 1, 2025 — Forward-Looking Statements — This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Ashland has identified some of these forward-looking statements with words such as "anticipates," "believes," "expects," "estimates," "is likely," "predicts," "projects," "forecasts," "objectives," "may," "will," "shoul ...

Ashland (ASH) Q2 2025 Earnings Call May 01, 2025 10:00 AM ET Speaker0 Hello, and welcome to Ashland's Second Quarter Fiscal Year twenty twenty five Earnings Conference Call and Webcast. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you will need to press 11 on your telephone. You would then hear an automatic message advising your hand is raised. To withdraw your question, please p ...

文章核心观点 - 公司2025年第一季度财报显示营收和每股收益同比下降且低于市场预期 ，部分关键指标表现不佳 ，股票近期表现弱于大盘且被给予卖出评级 [1][3] 公司财务表现 - 2025年第一季度营收4.79亿美元 ，同比下降16.7% ，比Zacks共识预期的5.0882亿美元低5.86% [1] - 2025年第一季度每股收益0.99美元 ，去年同期为1.27美元 ，比共识预期的1.10美元低10.00% [1] 公司关键指标表现 - 过去一个月公司股价回报率为 -7.4% ，而Zacks标准普尔500综合指数变化为 -0.2% ，目前股票Zacks排名为4（卖出） ，短期内可能跑输大盘 [3] 公司各业务板块营收情况 - 生命科学业务营收1.72亿美元 ，两位分析师平均预估为1.7702亿美元 ，同比变化 -22.5% [4] - 中间体业务营收3700万美元 ，两位分析师平均预估为3638万美元 ，同比变化 -7.5% [4] - 特种添加剂业务营收1.34亿美元 ，两位分析师平均预估为1.4110亿美元 ，同比变化 -14.7% [4] - 个人护理业务营收1.46亿美元 ，两位分析师平均预估为1.6283亿美元 ，同比变化 -13.6% [4] 公司各业务板块调整后EBITDA情况 - 生命科学业务调整后EBITDA为5600万美元 ，两位分析师平均预估为5375万美元 [4] - 中间体业务调整后EBITDA为200万美元 ，两位分析师平均预估为615万美元 [4] - 特种添加剂业务调整后EBITDA为2600万美元 ，两位分析师平均预估为2522万美元 [4] - 个人护理业务调整后EBITDA为4400万美元 ，两位分析师平均预估为4625万美元 [4]

Ashland (ASH) came out with quarterly earnings of $0.99 per share, missing the Zacks Consensus Estimate of $1.10 per share. This compares to earnings of $1.27 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -10%. A quarter ago, it was expected that this chemical company would post earnings of $0.20 per share when it actually produced earnings of $0.28, delivering a surprise of 40%.Over the last four quarters, the company has s ...

Exhibit 99.1 Ashland reports second quarter fiscal 2025 results and revises full-year outlook WILMINGTON, Del., April 30, 2025 – Ashland Inc. (NYSE: ASH) today announced financial results 1 for the second quarter of fiscal year 2025, which ended March 31, 2025, and revised its full-year fiscal 2025 outlook. Ashland, a global additives and specialty ingredients company, holds leadership positions in high-quality, consumer-focused markets including pharmaceuticals, personal care and architectural coatings. "O ...